Viking Therapeutics (VKTX) Return on Equity (2016 - 2025)
Historic Return on Equity for Viking Therapeutics (VKTX) over the last 11 years, with Q3 2025 value amounting to 0.31%.
- Viking Therapeutics' Return on Equity fell 2100.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year decrease of 2100.0%. This contributed to the annual value of 0.18% for FY2024, which is 1700.0% up from last year.
- As of Q3 2025, Viking Therapeutics' Return on Equity stood at 0.31%, which was down 2100.0% from 0.21% recorded in Q2 2025.
- In the past 5 years, Viking Therapeutics' Return on Equity registered a high of 0.1% during Q2 2024, and its lowest value of 0.52% during Q1 2023.
- For the 5-year period, Viking Therapeutics' Return on Equity averaged around 0.25%, with its median value being 0.24% (2023).
- As far as peak fluctuations go, Viking Therapeutics' Return on Equity plummeted by -2200bps in 2023, and later soared by 3700bps in 2024.
- Viking Therapeutics' Return on Equity (Quarter) stood at 0.26% in 2021, then tumbled by -75bps to 0.46% in 2022, then skyrocketed by 48bps to 0.24% in 2023, then soared by 49bps to 0.12% in 2024, then crashed by -156bps to 0.31% in 2025.
- Its Return on Equity stands at 0.31% for Q3 2025, versus 0.21% for Q2 2025 and 0.15% for Q1 2025.